Cited by 164Pancreatic function and diabetesReceptor Mechanisms and SignalingNeuropeptides and Animal Physiology

SSTR2 is the functionally dominant somatostatin receptor in human pancreatic β- and α-cells

Open access
Kailey, Balrik, van de Bunt, Martijn, Cheley, Stephen, Johnson, Paul R., MacDonald, Patrick E., Gloyn, Anna L., Rorsman, Patrik, Braun, Matthias·2012·American Journal of Physiology-Endocrinology and Metabolism

Abstract

Somatostatin-14 (SST) inhibits insulin and glucagon secretion by activating G protein-coupled somatostatin receptors (SSTRs), of which five isoforms exist (SSTR1–5). In mice, the effects on pancreatic β-cells are mediated by SSTR5, whereas α-cells express SSTR2. In both cell types, SSTR activation results in membrane hyperpolarization and suppression of exocytosis. Here, we examined the mechanisms by which SST inhibits secretion from human β- and α-cells and the SSTR isoforms mediating these effects. Quantitative PCR revealed high expression of SSTR2, with lower levels of SSTR1, SSTR3, and SSTR5, in human islets. Immunohistochemistry showed expression of SSTR2 in both β- and α-cells. SST application hyperpolarized human β-cells and inhibited action potential firing. The membrane hyperpolarization was unaffected by tolbutamide but antagonized by tertiapin-Q, a blocker of G protein-gated inwardly rectifying K+ channels (GIRK). The effect of SST was mimicked by an SSTR2-selective agonist, whereas a SSTR5 agonist was marginally effective. SST strongly (>70%) reduced depolarization-evoked exocytosis in both β- and α-cells. A slightly weaker inhibition was observed in both cell types after SSTR2 activation. SSTR3- and SSTR1-selective agonists moderately reduced the exocytotic responses in β- and α-cells, respectively, whereas SSTR4- and SSTR5-specific agonists were ineffective. SST also reduced voltage-gated P/Q-type Ca 2+ currents in β-cells, but normalization of Ca 2+ influx to control levels by prolonged depolarizations only partially restored exocytosis. We conclude that SST inhibits secretion from both human β- and α-cells by activating GIRK and suppressing electrical activity, reducing P/Q-type Ca 2+ currents, and directly inhibiting exocytosis. These effects are mediated predominantly by SSTR2 in both cell types.

Integrity signals

Registry

Crossref · 10.1152/ajpendo.00207.2012

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Adrenaline and somatostatin lead to transient repolarization and suppression of glucose-induced electrical activity in human β-cells.

    “Adrenaline and somatostatin lead to transient repolarization and suppression of glucose-induced electrical activity (327, 568).”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Kailey, B., van de Bunt, M., Cheley, S., Johnson, P. R., MacDonald, P. E., Gloyn, A. L., Rorsman, P., & Braun, M.
Affiliations
  • University of Oxford (GB)
  • Oxford Centre for Diabetes, Endocrinology, and Metabolism, University of Oxford, Oxford, United Kingdom;
  • University of Alberta (CA)
  • John Radcliffe Hospital (GB)
  • National Institute for Health and Care Research (GB)
Corresponding author
Braun, Matthias
Venue
American Journal of Physiology-Endocrinology and Metabolism
Published
2012-11-01
Volume
303
Issue
9
Pages
E1107-E1116
ISSN
  • 0193-1849 (ISSN-L)
  • 1522-1555
OpenAlex
W2144387356
Cited by
164
References
6
Citations by year
2026: 16 · 2025: 14 · 2024: 15 · 2023: 13 · 2022: 12 · 2021: 17 · 2020: 14 · 2019: 13 · 2018: 10 · 2017: 7 · 2016: 6 · 2015: 9 · 2014: 7 · 2013: 10 · 2012: 1
FWCI
8.79
Type
journal article
Language
en
Open access
Locations
  • American Journal of Physiology-Endocrinology and Metabolism (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Wellcome Trust (095331/Z/11/Z, 095101, 095531/Z/11/Z, 095531, 95101/Z/10/Z)
  • Canadian Institutes of Health Research (106435_1)
Topics
  • Health Sciences › Medicine › Surgery › Pancreatic function and diabetes
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
Keywords
somatostatin, somatostatin receptor 2, somatostatin receptor 5, pancreatic beta cells, alpha cells, insulin secretion, glucagon secretion, membrane hyperpolarization, exocytosis, G protein-coupled receptors, G protein-coupled inwardly rectifying potassium channels, tertiapin-Q, action potential firing, human pancreatic islets
MeSH terms
Cells, Cultured, Exocytosis, Gene Expression Regulation, Humans, Immunohistochemistry, Islets of Langerhans, Kinetics, Membrane Potentials, Recombinant Proteins, RNA, Messenger, Somatostatin, Receptors, Somatostatin, Patch-Clamp Techniques, Calcium Signaling, Protein Isoforms, Protein Subunits, Potassium Channel Blockers, Glucagon-Secreting Cells, Insulin-Secreting Cells, G Protein-Coupled Inwardly-Rectifying Potassium Channels

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review